Profile: Berkeley Heartlab, Inc. provides cardiovascular disease(CVD) management tools and services. Our approach includes assays that determine lipoprotein particle size and density, based on proprietary segmented gradient gel electrophoresis technology & genetic testing. Our 4myheart program features a patient-centric approach to help educate patients on how to improve cardiac health. It enables clinician access to updates on patient compliance & outcomes, clinical educators to provide support for patients in person, by phone, or online, personalized cardiovascular disease risk reduction recommendations for each patient based on test results, and community sessions that help patients connect with each other, & encourage adherence to lifestyle modifications.